AFI

No formal guidance or forward target was provided. The shape context is noisy: HY21 represented only 40.9% of FY21 revenue and 35.6% of FY21 NPAT, so the prior year was heavily second-half weighted as dividends resumed. Annualising HY22 revenue gives roughly $323.5m, about 37.6% above FY21's $235.1m, but this should not be read as a run-rate given the one-off nature of the HY21 compression. The release supports the view that investment income has re-based higher; it does not support a specific full-year figure.

• The release excerpts do not disclose NTA per share, so price-to-NTA and the premium/discount position cannot be assessed here.
• Portfolio composition, concentration, and the sources of the dividend recovery by investee are not in the supplied data; the mix between special and ordinary distributions received is also not broken out.
• The reason for introducing $10.0m of bank debt while cash fell $14.2m is not explained in the excerpts.
• Capex and any company-defined free cash flow measure are not disclosed, though these are less relevant for an LIC structure.

This briefing cannot assess the portfolio's current market value, discount or premium to NTA, or any post-balance-date changes in underlying investee dividend policies.